About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

MASLD in Type 2 Diabetes in Primary Care - a Follow-up Study

NCT07312136·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Linkoeping University

With

University Hospital, Linkoeping
Amra Medical AB

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Previously included and fulfilled evaluation in EPSONIP trial (NCT03864510)
Age \>/= 18 years
Informed consent

You may not be if

Contraindication to magnetic resonance
Other primary liver disease than MASLD diagnosed after inclusion EPSONIP trial (NCT03864510)
Liver transplantation

The record

StatusEnrolling by invitation

PhaseNo phase

Taking part317

StartedDec 2025

UpdatedDec 31, 2025

Conditions

Cirrhosis Advanced Fibrosis Sarcopenia Obesity & Overweight Type 2 Diabetes+3

Where1

Department of Gastroenterology and Hepatology, Linköping University Hospital
Linköping, Östergötland County, Sweden

Clareo Health | MASLD in Type 2 Diabetes in Primary Care - a Follow-up Study